상세 보기

A phase II trial of ifosfamide, methotrexate, etoposide, and prednisolone (IMEP) for previously untreated stage I, II extranodal natural killer/T-cell lymphoma, nasal type (NTCL): A multicenter study of the Korean Cancer Study Group

Kim, Tae Min;
Kim, Dong-Wan;
Kang, Yoon-Koo;
Cho, Goon Jae;
Song, Hong-Suk;
... Kim, Byung Soo;
외 10명

제목: A phase II trial of ifosfamide, methotrexate, etoposide, and prednisolone (IMEP) for previously untreated stage I, II extranodal natural killer/T-cell lymphoma, nasal type (NTCL): A multicenter study of the Korean Cancer Study Group

저자: Kim, Tae Min; Kim, Dong-Wan; Kang, Yoon-Koo; Cho, Goon Jae; Song, Hong-Suk; Kim, Hyo Jung; Kim, Byung Soo; Lee, Jong-Seok; Kim, Hawk; Yang, Sung Hyun; Yuh, Young Jin; Bae, Sung Hwa; Lee, Kyung-Hee; Jeon, Yoon-Kyung; Kim, Chul Woo; Heo, Dae Seog

DOI: 10.1200/jco.2013.31.15_suppl.8521

발행일: 2013-05-20

학회명: 49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)

개최지: Chicago, IL

개최국가: 미국

학회 개최일: 2013-05-31 ~ 2013-06-04

언어: ENG